Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Comparison of Ketamine and Esketamine in Ambulatory Patients Treated for Fibromyalgia Syndrome in Pain Clinic. A Single-center, Prospective, Randomized, Double-blind, Crossover Study.

To see complete record on, please visit this link

Id: NCT04938713

Organisation Name: Centre Hospitalier Universitaire de Charleroi

Overal Status: Recruiting

Start Date: July 1, 2021

Last Update: August 27, 2021

Lead Sponsor: Centre Hospitalier Universitaire de Charleroi

Brief Summary: Ketamine and Esketamine intravenous perfusions can modulate chronic pain. The purpose of this study is to determine if Ketamine or Esketamine are favorable for outpatients suffering from fibromyalgia.

  • Fibromyalgia

Total execution time in seconds: 0.19363903999329